Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

tamiflu

Cancer drugs boost Roche

April 12, 2013
Sales and Marketing Cancer, Q1, Roche

Roche saw overall sales rise 6% year-on-year in the first three months of this year on the back of a …

News
roche_close

Roche signs Huntington’s deal

April 10, 2013
Research and Development, Sales and Marketing Huntington's, Isis, Roche

Roche is to pay California-based Isis Pharmaceuticals $30 million upfront to cement a new alliance in which the firms will …

News
roche_humer

Roche chairman standing down

March 13, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, humer

The chairman of the Board of directors at Roche, Franz Humer, has announced that he will not stand for re-election …

Appointment
roche image

Roche bins Galapagos tie-up

March 12, 2013
Sales and Marketing COPD, Galapagos, Roche

Roche has ended its three-year old alliance with Belgian drug discovery specialist Galapagos because of a ‘strategic change’. The companies …

News

Contract research news in brief

March 11, 2013
Research and Development Accelovance, BioLamina, Clinstar LLC, Critical Path Services, PRA, PSI CRO, Radiant Development, Roche, Synta

Consolidation news in the CRO sector as Accelovance buys Radiant and PRA snaps up Clinstar, plus updates from Roche/BioLamina, PSI …

News
Roche image

Perjeta approved in EU

March 7, 2013
Sales and Marketing Perjeta, Roche

Roche’s oncology brand Perjeta has been approved in Europe to treat patients with an aggressive form of breast cancer. The …

News
Roche image

Roche increases data access

February 27, 2013
Research and Development, Sales and Marketing ABPI, BMJ, Goldacre, Roche

Roche has launched a new process designed to enable greater access to its clinical trial data for researchers from outside …

News
herceptinbank

FDA approves Kadcyla

February 25, 2013
Herceptin, Roche, T-DM1

Roche’s new ‘smart bomb’ breast cancer drug Kadcyla has been approved by the FDA, giving it hope of replacing revenue …

News
Roche image

Roche censured for drunken conference antics

February 21, 2013
Medical Communications, Sales and Marketing ABPI, PMCPA, Roche

The conduct of senior Roche employees has come under the spotlight following a complaint about drunkenness and poor behaviour at …

News
FDA image

FDA offers Alzheimer’s guidance

February 11, 2013
Research and Development, Sales and Marketing Alzheimer's, FDA, Roche, lilly

The FDA has issued guidance to help companies developing new treatments for patients with early-stage Alzheimer’s disease. The US regulator’s …

News
Roche image

Facility of the year: 2013 winners announced

February 4, 2013
Manufacturing and Production Biogen, MedImmune, Merck, Novartis, Roche

Three US and three European manufacturing plants have been selected as category winners for the annual Facility of the Year …

News
john_reed

Roche adds head to corporate executive committee

January 23, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John Reed, Roche

Roche has announced that John Reed has been appointed as head of Roche Pharma Research and Early Development (pRED) and …

Appointment

Perjeta recommended in EU

December 18, 2012
Sales and Marketing CHMP, Cancer, Perjeta, Roche

Roche’s breast cancer treatment Perjeta has been given the thumbs up by the CHMP, paving the way for its approval …

News
Roche image

Swiss Re helps Roche open up China’s oncology market

December 17, 2012
Sales and Marketing Cancer, China, Roche, Swiss re, oncology

Roche and reinsurance firm Swiss Re have teamed up to find an innovative way into China’s healthcare market. For the …

News
Roche image

Roche plans €200m investment in diagnostics facility

December 12, 2012
Manufacturing and Production Diagnostics, Roche

Roche has said it intends to invest more than €200 million ($260m) in the construction of a new production plant …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026